Follow the podcast on
Two cheap and widely available drugs have been found to help save patients critically ill with Covid-19, international research involving New Zealand experts has concluded.
The steroid treatments have proven major breakthroughs in the fight against the deadly virus, with fewer patients dying and less intensive care unit (ICU) support needed, compared to usual treatment.
"It's proven to be the most effective treatment," said Dr Colin McArthur, intensivist and researcher at Auckland City Hospital who leads the New Zealand arm of the trial and is a co-author of the World Health Organisation meta-analysis, published today in the Journal of the American Medical Association (JAMA).
The drugs, hydrocortisone and dexamethasone, cut the risk of death for those needing ICU care by 20 per cent, with one extra patient surviving for every 11 treated.
The findings reinforced the United Kingdom-based RECOVERY trial, published in July, which found dexamethasone cut the risk of death by a third for patients on ventilators, and a fifth for those on oxygen.
Take your Radio, Podcasts and Music with you